The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to older adults and those at risk of developing severe illness.

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy

FDA FLAGS SEVERE ITCH — Patients who stop using the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) may experience rare but severe itching after longtime use, the FDA has cautioned.

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65, effectively limiting their availability later this year to older adults and those at risk of developing severe illness,

In response, the U.S. Congress passed the Federal Food, Drug and Cosmetic Act of 1938, granting FDA with “premarket review” powers to ensure that products were safe before they were marketed to the public. Congress expanded these powers in 1976 to cover devices and again in 2009 to include tobacco.

By Stephanie Brown HealthDay ReporterMONDAY, May 19, 2025 (HealthDay News) -- Last week, the U.S. Food and Drug Administration announced a move to improve transparency and strengthen the safety of chemicals used in the nation's food supply.

Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy

Nearly 4,500 cases were pulled from shelves in 23 states after it was found that the affected cans had been mislabeled.